Sale!

Metapneumonia Viral Load Quantitative Test Cost

Original price was: 2,000 د.إ.Current price is: 1,700 د.إ.

-15%

The Metapneumonia Viral Load Quantitative Test is a specialized diagnostic tool used to measure the amount of metapneumovirus present in a patient’s body. This virus is responsible for causing respiratory infections, particularly in children, the elderly, and individuals with weakened immune systems. By quantifying the viral load, healthcare providers can assess the severity of the infection, monitor the progression of the disease, and tailor treatment strategies accordingly.

This test is particularly useful in cases where metapneumovirus is suspected to be the cause of respiratory distress, allowing for early and accurate detection. The quantitative aspect of the test provides a clear picture of the viral concentration, which is crucial for determining the stage of infection and evaluating the patient’s response to treatment over time.

Conducted at DNA Labs UAE, a leading facility in medical diagnostics, the test ensures accuracy and reliability. The cost of the Metapneumonia Viral Load Quantitative Test is set at 1700 AED. This price reflects the sophisticated technology and expertise required to perform this advanced molecular diagnostic test. Patients seeking this test can expect a high standard of service and reliable results that can significantly aid in the management of infections caused by the metapneumovirus.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

Metapneumonia Viral Load Quantitative Test

At DNA Labs UAE, we offer the Metapneumonia Viral Load Quantitative Test to measure the amount of metapneumovirus in a patient’s respiratory samples. This diagnostic test is essential for identifying and monitoring metapneumovirus infections.

Test Details

The Metapneumonia Viral Load Quantitative Test is a molecular diagnostic test that uses polymerase chain reaction (PCR) to detect and quantify the genetic material of the metapneumovirus in the patient’s sample. It is particularly useful in immunocompromised patients, young children, and the elderly who may be at a higher risk of developing severe complications from metapneumovirus infection.

Components and Price

The test costs AED 1700.0 and requires respiratory samples such as bronchial swab, bronchial lavage, sputum, nasopharyngeal (NP) aspirates and swabs in viral transport medium, or lung tissues.

Report Delivery

The test report is delivered via email within 3 working days (36 hours) and can also be obtained over the phone within 24 hours.

Pre Test Information

Prior to the test, patients need to sign a consent document and bring any relevant clinical history of the patient for the Metapneumonia Viral Load Quantitative Test.

Symptoms and Diagnosis

Metapneumovirus is a common respiratory virus that can cause symptoms similar to those of the common cold or flu, including cough, fever, and congestion. The Metapneumonia Viral Load Quantitative Test is used to differentiate metapneumovirus infection from other respiratory infections with similar symptoms.

Doctor and Test Department

The test is conducted by a physician in our Genetics department.

Test Results and Interpretation

The test results are reported as a numerical value, indicating the number of viral copies present in the patient’s sample. A higher viral load typically indicates a more severe infection. However, it is important to note that the viral load alone does not determine the severity of symptoms or the prognosis of the infection, as other factors, such as the patient’s immune response, also play a role.

Overall, the Metapneumonia Viral Load Quantitative Test is a valuable tool for diagnosing and monitoring metapneumovirus infections, allowing healthcare providers to provide appropriate treatment and care to affected individuals.

Test Name Metapneumonia Viral Load Quantitative Test
Components
Price 1700.0 AED
Sample Condition Bronchial Swab, Bronchial Lavage, Sputum, Nasopharyngeal (NP) aspirates and swabs in viral transport medium, or lung tissues, ETC.
Report Delivery 3rd Working Day Email:-36 hours.On phone: 24 hours
Method Real Time PCR
Test type Viral
Doctor Physician
Test Department: Genetics
Pre Test Information Need to sign Consent document and bring any clinical history of patient forMetapneumonia Viral Load QuantitativeTest
Test Details

The Metapneumonia Viral Load Quantitative Test is a diagnostic test used to measure the amount of metapneumovirus in a patient’s respiratory samples, such as nasal swabs or bronchoalveolar lavage fluid. Metapneumovirus is a common respiratory virus that can cause symptoms similar to those of the common cold or flu, including cough, fever, and congestion.

The test uses molecular techniques, such as polymerase chain reaction (PCR), to detect and quantify the genetic material of the metapneumovirus in the patient’s sample. By measuring the viral load, healthcare providers can assess the severity of the infection and monitor the effectiveness of treatment.

The Metapneumonia Viral Load Quantitative Test is particularly useful in immunocompromised patients, young children, and the elderly who may be at a higher risk of developing severe complications from metapneumovirus infection. It can also be used to differentiate metapneumovirus infection from other respiratory infections with similar symptoms.

The test results are usually reported as a numerical value, indicating the number of viral copies present in the patient’s sample. A higher viral load typically indicates a more severe infection. However, it is important to note that the viral load alone does not determine the severity of symptoms or the prognosis of the infection, as other factors, such as the patient’s immune response, also play a role.

Overall, the Metapneumonia Viral Load Quantitative Test is a valuable tool for diagnosing and monitoring metapneumovirus infections, allowing healthcare providers to provide appropriate treatment and care to affected individuals.